Brazil Advanced Wound Dressings Market: Growth, Size, Share, and Trends

Report Code MD 9445
Published in Jul, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Brazil Advanced Wound Dressings Market by Product (Foam, Hydrocolloid, Film, Alginate, Gelling Fiber, Collagen), Wound Type (Chronic (Diabetic Foot Ulcer, Pressure Ulcer), Acute (Surgical, Burn)), End User (Hospital, Clinic, ASC)- Forecast to 2030

Overview

The global Brazil advanced wound dressings market, valued at US$117.79 million in 2024, stood at US$129.84 million in 2025 and is projected to advance at a resilient CAGR of 10.4% from 2025 to 2030, culminating in a forecasted valuation of US$213.03 million by the end of the period. The rising prevalence of diabetes and obesity, coupled with an increasing incidence of traumatic and burn injuries, significantly contributes to market expansion. The escalating venous leg ulcers and pressure ulcers also influence this growth trajectory. Moreover, the ongoing development of the healthcare system, particularly within the framework of Brazil's Sistema Único de Saúde (SUS), presents a favorable environment for market opportunities.

Brazil Advanced Wound Dressings Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Brazil Advanced Wound Dressings Market

Brazil

The advanced wound dressings market in Brazil is growing due to the rising prevalence of chronic conditions, diabetes, obesity and an increasing number of venous ulcers, pressure ulcers, and non-healing wounds among the elderly, leading to a demand for effective wound management solutions.

Foam dressings hold the largest product market share due to their versatility, high absorbency, and effectiveness in chronic wounds such as diabetic foot ulcers and pressure ulcers.

In 2024, the chronic wounds segment commanded the largest market share of 54.0% due to the high occurrence and long treatment needs among diabetic and elderly populations.

By end user, hospitals & clinics hold a large market share due to the high volume of chronic wound cases requiring prolonged care and greater access to specialized treatment and medical infrastructure.

ConvaTec leads the market due to its focus on both the public and private sectors, with a particular emphasis on products, such as AQUACEL, which enhances its market presence.

Global Brazil Advanced Wound Dressings Market Dynamics

DRIVER: Increased prevalence of non-healing wounds among geriatric population

In Brazil, the demographic shift towards an aging population is significant, with individuals aged 65 and older constituting 10.6% of the total population in 2023. The national census data indicates a remarkable 57.4% increase in the elderly demographic, jumping from 14.1 million in 2010 to 22.1 million in 2022; this trend is exerting increasing pressure on Brazil’s healthcare infrastructure, particularly in managing chronic conditions and the associated challenges of aging, such as protracted wound healing and extended recovery times. Among the elderly, conditions such as diabetic foot ulcers (DFUs) and pressure ulcers are prevalent, driven by age-related physiological changes, including diminished skin elasticity, reduced collagen synthesis, compromised microcirculation, and an attenuated immune response. As the population of older adults expands, the incidence of acute, chronic, and surgical wounds is anticipated to escalate, thereby propelling growth in the Brazil advanced wound dressings market. These advanced dressings are critical in optimizing the management of both acute and chronic wounds, effectively mitigating the risks of infections and other complications associated with impaired healing processes.

RESTRAINT: Higher expenditure related to advanced wound dressings

The escalating costs of advanced wound care products pose significant challenges for continuous usage, particularly in cost-sensitive markets where consumers and healthcare providers often seek more economical alternatives due to financial constraints and limited insurance coverage. A study published in SciELO indicates that in Brazil, annual medical expenses associated with diabetic foot ulcers amount to USD 100 million, with 87% attributed to outpatient care and 13% to hospital admissions. Despite the availability of sophisticated, advanced wound care dressings, traditional products remain more appealing to many due to their lower cost. Dry dressings, in particular, are considerably less expensive than their advanced counterparts, contributing to a persistent reliance on conventional methods among consumers and medical professionals. This cost disparity has impeded the broader adoption of more advanced treatment options. However, a shift is anticipated as awareness of the benefits of advanced wound care products increases, coupled with rising disposable incomes in various regions. Although advanced dressings have a higher initial cost, they are changed less frequently than traditional dressings, potentially leading to overall cost savings by reducing labor expenditures; this changing landscape may foster greater integration of advanced wound care solutions in clinical practice over time.

 

OPPORTUNITY: Favorable regulatory framework in Brazil by Sistema Único de Saúde (SUS)

In Brazil, legal residents benefit from a universal and free healthcare system through the Sistema Único de Saúde (SUS), which is orchestrated at the national level by the Ministry of Health and implemented through a collaborative framework involving federal, state, and municipal entities. SUS encompasses a comprehensive suite of services, including preventive care, outpatient treatment, hospitalization, mental health support, and home care, addressing various health needs. The system's operational strategies are informed by key strategic documents such as the Multi-Annual Plan and the National Health Plan (Plano Nacional de Saúde, PNS) for 2020–2023, prioritizing national health objectives. A crucial aspect of the PNS is that it manages acute and chronic wounds, ensuring a seamless transition from initial treatment to long-term recovery pathways. The PNS delineates seven foundational programs to enhance public health metrics: optimize pharmaceutical services within SUS; expand access to specialized healthcare; fortify primary health care (PHC); foster scientific, technological, and productive advancements in health; improve the organization and management of SUS; enhance health protection and recovery initiatives for Indigenous communities; and strengthen health surveillance systems. These strategic initiatives facilitate superior prevention, early diagnosis, and ongoing management of complex wound care, encompassing conditions such as diabetic ulcers and pressure injuries. Consequently, this enables healthcare providers to address advanced wound care requirements effectively, thereby minimizing patient reliance on private healthcare services.

CHALLENGES: Late detection of chronic wounds and inadequate awareness

Patients in low-income countries, such as Brazil, often struggle to obtain comprehensive diagnoses for chronic wounds due to inadequate healthcare infrastructure and a lack of awareness among both providers and patients. This situation is exacerbated by the absence of established medical protocols, limited access to advanced diagnostic and therapeutic modalities, and a general unawareness of the implications associated with protracted wound healing. Delays in diagnosis and treatment can lead to serious complications, extending rehabilitation periods and placing additional strain on healthcare systems already facing resource constraints. Many individuals may be unable to identify early warning signs of chronic wound complications, resulting in deferred medical intervention. Consequently, inadequate wound management becomes prevalent, contributing to prolonged recovery times, increased susceptibility to infections, escalated treatment costs, and an overall decline in patient health status. The repercussions can be particularly severe for patients with chronic comorbidities, such as diabetes, which heightens the risk of severe infections and potential amputations. Implementing timely diagnostic and therapeutic interventions could alleviate the burden on Brazil's healthcare system by minimizing complications and enhancing healing outcomes. Therefore, there is a pressing need for enhanced educational initiatives, improved access to medical treatment, and the integration of standardized wound care protocols to address these challenges effectively.

Global Brazil Advanced Wound Dressings Market Ecosystem Analysis

The ecosystem market map of Brazil advanced wound dressings market includes the various elements involved and outlines the key stakeholders. Manufacturers of advanced wound dressings in Brazil consist of organizations focused on research, product development, optimization, and product launch. Delivering these products to end users—clinics, hospitals, and other healthcare facilities—is crucial, as they rely on Brazil's advanced wound dressings to treat various acute and chronic wounds. Regulatory agencies monitor the safety, quality, and compliance of these products with industry standards. End users, including clinics, hospitals, and healthcare providers, depend on these dressings at different stages of wound care. These stakeholders collaborate to create an effective supply chain, ensuring patients receive quality wound care.

Brazil Advanced Wound Dressings Market Ecosystem
 

By product, the foam dressings segment accounted for the largest market share in 2024.

The Brazil advanced wound dressings market is categorized into various types: foam dressings, xeroform dressings, hydrocolloid dressings, film dressings, alginate dressings, gelling fiber dressings, collagen dressings, and other advanced wound dressings. As of 2024, foam dressings have emerged as the dominant segment in Brazil's market. Foam dressings are particularly valued for their versatility and efficacy in managing various wound types. Their inherent absorbent properties help maintain a moist wound environment, which is essential for optimal healing and infection prevention. This characteristic is particularly advantageous for chronic wounds, such as diabetic foot ulcers and pressure ulcers. Moreover, foam dressings are cost-effective and user-friendly, making them a practical choice for clinical settings and home care. Foam dressings also offer excellent cushioning and protection, which is crucial for wounds located in pressure-prone areas. Their conformability allows for easy application on various body contours, enhancing patient comfort and dressing adherence. The availability of different shapes and sizes further contributes to their widespread adoption across diverse wound care needs. Overall, the ability of foam dressings to facilitate expedited healing processes solidifies their status as a preferred option among healthcare professionals and individuals seeking effective and comfortable wound management.

By wound type, chronic wounds are projected to grow at the highest CAGR during the forecast period.

The Brazilian advanced wound dressings market is categorized into two primary segments based on application: acute wounds and chronic wounds. In 2024, chronic wounds are projected to dominate the market share and exhibit the highest CAGR during the forecast period. This growth trend is primarily driven by the extended treatment durations and elevated incidence rates, particularly among diabetic and elderly populations, who often require specialized wound care solutions. The market is further segmented within the chronic wound category into diabetic foot ulcers, pressure ulcers, and other chronic wound types, each necessitating tailored therapeutic strategies. The significance of these segments is underscored by the prevalence and substantial healthcare costs associated with treating diabetic foot ulcers and pressure ulcers in Brazil. Notably, diabetic foot ulcers are anticipated to capture the largest share of the chronic wound segment, approximately 50% in 2024. As the incidence of chronic wound conditions continues to escalate, the demand for innovative, effective treatments intensifies, prompting the healthcare sector to seek advanced solutions actively. Ensuring consumer safety and the clinical efficacy of available wound care products remains paramount, reinforcing the critical role of advanced wound care technologies in the management of chronic wounds.

By end user, hospitals & clinics accounted for largest market share in 2024.

The Brazil advanced wound dressings market, categorized by the end user, includes sectors such as hospitals & clinics, ambulatory surgery centers, home care settings, and other end users. In 2024, the hospitals & clinics segment is expected to dominate this market segment, driven primarily by the escalating prevalence of pressure ulcers and post-operative wounds. The uptick in hospital visits for wound management can be attributed to the growing elderly demographic, particularly those with chronic conditions such as diabetes and vascular diseases. This setting is well-equipped to deliver prompt and effective wound care thanks to established protocols, a skilled healthcare workforce, and a diverse array of advanced dressing materials. Moreover, the commitment to enhancing wound care methodologies and improving patient outcomes has solidified this segment's leading market position. The integration of innovative wound care solutions is paramount in addressing the complex needs of patients during their recovery process.

AMBULATORY SURGERY CENTRES: FASTEST-GROWING MARKET IN BRAZIL IN 2024
HOSPITALS & CLINICS: LARGEST END USER MARKET SHARE IN BRAZIL IN 2024
Brazil Advanced Wound Dressings Market Region

Recent Developments of Brazil Advanced Wound Dressings Market

  • Product Launch: In January 2023, Convatec Group PLC (UK) introduced ConvaFoam, a foam dressing with silicon technology that improves fluid handling and has a superabsorbent layer.
  • Acquisition: In March 2022, Owens & Minor (US) acquired Apria, Inc. (US) to combine its Byaram healthcare business with Apria and expand their home healthcare portfolio.

Key Market Players

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion)
Segments covered Product, Wound Type, and End User
Geographies covered

Convatec Group PLC (UK), Smith+Nephew (UK), Coloplast Group (Denmark), Mölnlycke AB (Sweden), Solventum (US), PAUL HARTMANN AG (Germany), Essity Aktiebolag (Sweden), B. Braun SE (Germany), Cardinal Health (US), Owens & Minor (US), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), AVERY DENNISON CORPORATION (US), Lohmann & Rauscher GmbH & Co. KG (Germany), Medline Industries, LP (US), DeRoyal Industries, Inc. (US), Triage Meditech (India), MISSNER & MISSNER LTDA (Brazil), Winner Medical Co., Ltd. (China), URGO Medical (France), Gentell (US), Cremer S.A (Brazil), and Advancis (UK)

Frequently Asked Questions (FAQ)

Which are the top industry players in the Brazil advanced wound dressings market?

The key players include Convatec Group PLC (UK), Smith+Nephew (UK), Coloplast Group (Denmark), Mölnlycke AB (Sweden), Solventum (US), PAUL HARTMANN AG (Germany), Essity Aktlebolag (Sweden), B. Braun SE (Germany), Cardinal Health (US), and Owens & Minor (US).

What are some of the major drivers for this market?

Major drivers include the increasing cases of diabetes, aging population, rising incidents of burns and trauma, and the growing prevalence of obesity, all contributing to higher demand for advanced wound care products.

Which products have been included in the Brazil advanced wound dressings market?

Product segments include foam dressings, xeroform dressings, hydrocolloid dressings, film dressings, alginate dressings, gelling fiber dressings, collagen dressings, and other advanced wound dressings. In 2024, foam dressings accounted for the largest market share.

What are the end users profiled in the Brazil advanced wound dressings market?

End-user segments include Hospitals & Clinics, Ambulatory Surgery Centers, Home Care Settings, and Other End Users.

What are the key applications profiled in the Brazil advanced wound dressings market?

Application segments include: Chronic Wounds: Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds Acute Wounds: Surgical & Traumatic Wounds, Burns

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Brazil Advanced Wound Dressings Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
16
RESEARCH METHODOLOGY
20
EXECUTIVE SUMMARY
31
PREMIUM INSIGHTS
34
MARKET OVERVIEW
36
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing prevalence of chronic diseases
    - Growing prevalence of non-healing wounds among elderly
    - Increasing burden of burn injuries and traumatic wounds
    RESTRAINTS
    - Higher expenditure related to advanced wound dressing products
    - Potential risks linked to advanced wound dressing products
    OPPORTUNITIES
    - Favorable government initiatives and organizational frameworks
    - Availability of universal access to healthcare
    CHALLENGES
    - Shortage of trained healthcare professionals
    - Challenges arising from late detection of chronic wounds
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025
    INDICATIVE SELLING PRICE, BY WOUND TYPE, 2025
  • 5.5 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT (R&D)
    MANUFACTURING
    DISTRIBUTION AND MARKETING & SALES
    POST-SALES SERVICES
  • 5.6 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL & MEDIUM-SIZED ENTERPRISES
    END USERS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Portable negative pressure wound therapy devices
    ADJACENT TECHNOLOGIES
    - Telemedicine for wound care
    COMPLEMENTARY TECHNOLOGIES
    - Antimicrobial wound dressings
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 300510
    EXPORT DATA FOR HS CODE 300510
  • 5.12 KEY CONFERENCES AND EVENTS, 2025
  • 5.13 REGULATORY LANDSCAPE
    REGULATORY FRAMEWORK
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.16 IMPACT OF AI/GENERATIVE AI ON ADVANCED WOUND DRESSINGS MARKET
    INTRODUCTION
    POTENTIAL OF AI IN ADVANCED WOUND CARE
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI
    FUTURE OF GENERATIVE AI IN ADVANCED WOUND DRESSINGS
  • 5.17 IMPACT OF 2025 US TARIFF ON BRAZIL ADVANCED WOUND DRESSINGS MARKET
    INTRODUCTION
    KEY TARIFF RATES
BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY PRODUCT
62
  • 6.1 INTRODUCTION
  • 6.2 FOAM DRESSINGS
    SILICON DRESSINGS
    - Bordered silicon dressings
    - Non-bordered silicon dressings
    NON-SILICON DRESSINGS
    - High comfort & conformability to fuel market
    XEROFORM DRESSINGS
    - Provision of bacteriostatic properties to fuel higher adoption
    HYDROCOLLOID DRESSINGS
    - Increased functionality and enhanced collagen synthesis to drive market
    FILM DRESSINGS
    - Transparent & elastic properties to drive adoption
    ALGINATE DRESSINGS
    - High incidence of burn injuries to propel market
    GELLING DRESSINGS
    - Effective management of moderate to heavy exuding wounds to support market growth
    COLLAGEN DRESSINGS
    - Inflammatory control and facilitation of protein synthesis to drive market
    OTHER ADVANCED WOUND DRESSINGS
BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY WOUND TYPE
74
  • 7.1 INTRODUCTION
  • 7.2 CHRONIC WOUNDS
    DIABETIC FOOT ULCERS
    - Growing need for adjunct therapies to drive market
    PRESSURE ULCERS
    - Rising geriatric population and subsequent increase in comorbidities to fuel market
    VENOUS LEG ULCERS
    - Rising prevalence of obesity to support market growth
    OTHER CHRONIC WOUNDS
  • 7.3 ACUTE WOUNDS
    SURGICAL & TRAUMATIC WOUNDS
    - Increasing volume of surgical procedures due to trauma & road accidents to fuel market
    BURNS
    - High incidence of burn injuries to support market growth
BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY END USER
82
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CLINICS
    RISING INCIDENCE OF HAIS TO DRIVE MARKET
  • 8.3 AMBULATORY SURGERY CENTERS
    PROVISION OF SPECIALIZED WOUND CARE SERVICES TO PROPEL MARKET
  • 8.4 HOME CARE SETTINGS
    LOW COST AND CONVENIENCE TO BOOST DEMAND
  • 8.5 OTHER END USERS
COMPETITIVE LANDSCAPE
86
  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAZIL ADVANCED WOUND DRESSINGS MARKET
  • 9.3 REVENUE ANALYSIS, 2022−2024
  • 9.4 MARKET SHARE ANALYSIS, 2024
  • 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Product footprint
    - Wound type footprint
    - End-user footprint
  • 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 9.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
  • 9.8 COMPANY VALUATION & FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 9.9 BRAND/PRODUCT COMPARISON
COMPANY PROFILES
103
  • 10.1 KEY PLAYERS
    CONVATEC GROUP PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SMITH+NEPHEW
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    COLOPLAST GROUP
    - Business overview
    - Products offered
    - MnM view
    MÖLNLYCKE AB
    - Business overview
    - Products offered
    - MnM view
    SOLVENTUM
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CARDINAL HEALTH
    - Business overview
    - Products offered
    B. BRAUN SE
    - Business overview
    - Products offered
    PAUL HARTMANN AG
    - Business overview
    - Products offered
    ESSITY AKTIEBOLAG
    - Business overview
    - Products offered
    OWENS & MINOR
    - Business overview
    - Products offered
    - Recent developments
    INTEGRA LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    MATIV HOLDINGS, INC.
    - Business overview
    - Products offered
    AVERY DENNISON CORPORATION
    - Business overview
    - Products offered
  • 10.2 OTHER PLAYERS
    LOHMANN & RAUSCHER GMBH & CO. KG
    MEDLINE INDUSTRIES, LP
    TRIAGE MEDTECH
    MISSNER & MISSNER LTDA
    DEROYAL INDUSTRIES, INC.
    WINNER MEDICAL CO., LTD.
    URGO GROUP
    CREMER S.A.
    GENTELL
    ADVANCIS
APPENDIX
155
  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 11.3 CUSTOMIZATION OPTIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 BRAZIL ADVANCED WOUND DRESSINGS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 BRAZIL ADVANCED WOUND DRESSINGS MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 BRAZIL ADVANCED WOUND DRESSINGS MARKET: RISK ANALYSIS
  • TABLE 4 BRAZIL: POPULATION OF 65 YEARS AND ABOVE (% OF TOTAL POPULATION), 2019–2023
  • TABLE 5 POTENTIAL RISKS LINKED TO ADVANCED WOUND DRESSING PRODUCTS
  • TABLE 6 TOTAL HEALTH SPENDING, SPENDING PER PERSON IN BRAZIL, 2024–2028
  • TABLE 7 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025
  • TABLE 8 INDICATIVE SELLING PRICE, BY WOUND TYPE, 2025 (USD)
  • TABLE 9 BRAZIL ADVANCED WOUND DRESSINGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 10 IMPORT DATA FOR HS CODE 300510 (ADHESIVE DRESSINGS), 2020–2024 (USD MILLION)
  • TABLE 11 EXPORT DATA FOR HS CODE 300510 (ADHESIVE DRESSINGS), BY COUNTRY, 2020–2024 (USD MILLION)
  • TABLE 12 BRAZIL ADVANCED WOUND DRESSINGS MARKET: KEY CONFERENCES AND EVENTS, 2025
  • TABLE 13 BRAZIL: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
  • TABLE 16 KEY BUYING CRITERIA FOR ADVANCED WOUND DRESSING PRODUCTS, BY RANK
  • TABLE 17 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 18 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 19 KEY PRODUCTS OFFERED IN FOAM DRESSINGS MARKET
  • TABLE 20 FOAM DRESSINGS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 21 SILICON DRESSINGS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 22 KEY PRODUCTS OFFERED IN XEROFORM DRESSINGS MARKET
  • TABLE 23 KEY PRODUCTS OFFERED IN HYDROCOLLOID DRESSINGS MARKET
  • TABLE 24 KEY PRODUCTS OFFERED IN FILM DRESSINGS MARKET
  • TABLE 25 KEY PRODUCTS OFFERED IN ALGINATE DRESSINGS MARKET
  • TABLE 26 KEY PRODUCTS OFFERED IN GELLING DRESSINGS MARKET
  • TABLE 27 KEY PRODUCTS OFFERED IN COLLAGEN DRESSINGS MARKET
  • TABLE 28 OTHER ADVANCED WOUND DRESSINGS OFFERED
  • TABLE 29 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION)
  • TABLE 30 CHRONIC WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 31 TOP FIVE COUNTRIES FOR NUMBER OF PEOPLE WITH DIABETES IN SOUTH & CENTRAL AMERICA (20−79 YEARS) (MILLION)
  • TABLE 32 NUMBER OF ADULT PATIENTS (20−79 YEARS) WITH DIABETIC FOOT ULCERS (IN THOUSANDS)
  • TABLE 33 ACUTE WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 34 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 35 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BRAZIL ADVANCED WOUND DRESSINGS MARKET, 2022–2025
  • TABLE 36 BRAZIL ADVANCED WOUND DRESSINGS MARKET: DEGREE OF COMPETITION
  • TABLE 37 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PRODUCT FOOTPRINT
  • TABLE 38 BRAZIL ADVANCED WOUND DRESSINGS MARKET: WOUND TYPE FOOTPRINT
  • TABLE 39 BRAZIL ADVANCED WOUND DRESSINGS MARKET: END-USER FOOTPRINT
  • TABLE 40 BRAZIL ADVANCED WOUND DRESSINGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 41 BRAZIL ADVANCED WOUND DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 42 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2025
  • TABLE 43 BRAZIL ADVANCED WOUND DRESSINGS MARKET: DEALS, JANUARY 2022–FEBRUARY 2025
  • TABLE 44 BRAZIL ADVANCED WOUND DRESSINGS MARKET: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2025
  • TABLE 45 CONVATEC GROUP PLC: COMPANY OVERVIEW
  • TABLE 46 CONVATEC GROUP PLC: PRODUCTS OFFERED
  • TABLE 47 CONVATEC GROUP PLC: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2025
  • TABLE 48 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 49 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 50 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2025
  • TABLE 51 COLOPLAST GROUP: COMPANY OVERVIEW
  • TABLE 52 COLOPLAST GROUP: PRODUCTS OFFERED
  • TABLE 53 MÖLNLYCKE AB: COMPANY OVERVIEW
  • TABLE 54 MÖLNLYCKE AB: PRODUCTS OFFERED
  • TABLE 55 SOLVENTUM: COMPANY OVERVIEW
  • TABLE 56 SOLVENTUM: PRODUCTS OFFERED
  • TABLE 57 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2025
  • TABLE 58 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 59 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 60 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 61 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 62 PAUL HARTMANN AG: COMPANY OVERVIEW
  • TABLE 63 PAUL HARTMANN AG: PRODUCTS OFFERED
  • TABLE 64 ESSITY AKTIEBOLAG: COMPANY OVERVIEW
  • TABLE 65 ESSITY AKTIEBOLAG: PRODUCTS OFFERED
  • TABLE 66 OWENS & MINOR: COMPANY OVERVIEW
  • TABLE 67 OWENS & MINOR: PRODUCTS OFFERED
  • TABLE 68 OWENS & MINOR: DEALS, JANUARY 2022–FEBRUARY 2025
  • TABLE 69 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 70 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 71 MATIV HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 72 MATIV HOLDINGS, INC.: PRODUCTS OFFERED
  • TABLE 73 AVERY DENNISON CORPORATION: COMPANY OVERVIEW
  • TABLE 74 AVERY DENNISON CORPORATION: PRODUCTS OFFERED
  • TABLE 75 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 76 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW
  • TABLE 77 TRIAGE MEDTECH: COMPANY OVERVIEW
  • TABLE 78 MISSNER & MISSNER LTDA: COMPANY OVERVIEW
  • TABLE 79 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 80 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 81 URGO GROUP: COMPANY OVERVIEW
  • TABLE 82 CREMER S.A.: COMPANY OVERVIEW
  • TABLE 83 GENTELL: COMPANY OVERVIEW
  • TABLE 84 ADVANCIS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 BRAZIL ADVANCED WOUND DRESSINGS MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 BRAZIL ADVANCED WOUND DRESSINGS MARKET: YEARS CONSIDERED
  • FIGURE 3 BRAZIL ADVANCED WOUND DRESSINGS MARKET: RESEARCH DESIGN
  • FIGURE 4 BRAZIL ADVANCED WOUND DRESSINGS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 BRAZIL ADVANCED WOUND DRESSINGS MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 BRAZIL ADVANCED WOUND DRESSINGS MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE AND DESIGNATION
  • FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 9 BRAZIL ADVANCED WOUND DRESSINGS MARKET: CAGR PROJECTIONS (SUPPLY SIDE)
  • FIGURE 10 BRAZIL ADVANCED WOUND DRESSINGS MARKET: TOP-DOWN APPROACH
  • FIGURE 11 BRAZIL ADVANCED WOUND DRESSINGS MARKET: DATA TRIANGULATION
  • FIGURE 12 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PARAMETRIC ASSUMPTIONS
  • FIGURE 13 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 BRAZIL ADVANCED WOUND DRESSINGS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 INCREASING PREVALENCE OF CHRONIC WOUNDS AMONG GERIATRIC POPULATION TO DRIVE MARKET
  • FIGURE 17 HOSPITALS & CLINICS AND CHRONIC WOUNDS COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 18 BRAZIL ADVANCED WOUND DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 20 BRAZIL ADVANCED WOUND DRESSINGS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 BRAZIL ADVANCED WOUND DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 22 BRAZIL ADVANCED WOUND DRESSINGS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 INVESTMENT AND FUNDING SCENARIO, 2020−2025
  • FIGURE 24 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PATENT ANALYSIS, JANUARY 2015–MARCH 2024
  • FIGURE 25 BRAZIL ADVANCED WOUND DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 27 KEY BUYING CRITERIA FOR ADVANCED WOUND DRESSING PRODUCTS, BY END USER
  • FIGURE 28 AI USE CASES
  • FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS, 2022−2024 (USD MILLION)
  • FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 31 RANKING OF KEY PLAYERS IN BRAZIL ADVANCED WOUND DRESSINGS MARKET, 2024
  • FIGURE 32 BRAZIL ADVANCED WOUND DRESSINGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 33 BRAZIL ADVANCED WOUND DRESSINGS MARKET: COMPANY FOOTPRINT
  • FIGURE 34 BRAZIL ADVANCED WOUND DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
  • FIGURE 36 FINANCIAL METRICS, 2025
  • FIGURE 37 BRAZIL ADVANCED WOUND DRESSINGS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 38 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 39 SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
  • FIGURE 40 COLOPLAST GROUP: COMPANY SNAPSHOT (2024)
  • FIGURE 41 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024)
  • FIGURE 42 SOLVENTUM: COMPANY SNAPSHOT (2024)
  • FIGURE 43 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
  • FIGURE 44 B. BRAUN SE: COMPANY SNAPSHOT (2024)
  • FIGURE 45 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)
  • FIGURE 46 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024)
  • FIGURE 47 OWENS & MINOR: COMPANY SNAPSHOT (2024)
  • FIGURE 48 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 49 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 50 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

Existing sources were extensively used to gather information for this market study, including business publications, directories, and databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers). Reports such as white papers, annual reports, investor presentations, and company SEC filings were also examined, along with publications from government organizations [such as the National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), and the Global Burden of Disease Study]. This method allowed for the finding and gathering of crucial data. Important details about leading companies, the market's specific organization according to industry developments and significant changes in the market and technology were also learned from these sources. Furthermore, using secondary research made it possible to put together a list of the main companies in the industry.

Primary Research

For the primary research process, interviews were conducted with various people involved in both the supply and demand sides to gather different kinds of qualitative and quantitative information for this report. The main people interviewed on the supply side included experts in the field, such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other important leaders from key companies and organizations in the Brazil advanced wound dressings market. On the demand side, the main people interviewed included those from pharmaceutical companies, biotechnology companies, contract research organizations (CROs), pharmacies, medical device companies, and academic researchers and universities. This initial research was done to confirm how the market is divided, find out who the main companies in the market are, and get a better understanding of the important trends and forces that drive this market.

A breakdown of the primary respondents is provided below:

Brazil Advanced Wound Dressings Market

Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

To determine the total value of the Brazil advanced wound dressings market, yearly earnings were calculated by looking at the revenue of the main companies that make and sell these products in Brazil. All the important service providers in the country were identified. The major companies' revenue was tracked for the different types of products they offer. The Brazilian market was also broken down into different parts based on:

  • A list of the main companies selling these products in Brazil.
  • Providers in Brazil offer product mapping of advanced wound dressings.
  • The major listed companies make yearly income from advanced wound dressings (or the closest related business area).
  • Using the revenue of these major companies to estimate the total market value for each product type.
  • Adding up the market value of all these different product types to get the total value of the advanced wound dressings market in Brazil.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom-up approach and Top-down approach)

Brazil Advanced Wound Dressings Market

Data Triangulation

After arriving at the overall size of the Brazil advanced wound dressings market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Advanced wound dressings utilize foam dressings, hydrocolloid dressings, film dressings, and alginate dressings to facilitate the rapid healing and management of chronic ulcers, diabetic foot ulcers, burns, traumatic wounds, and surgical wounds. The adoption of advanced wound care provides early and smooth healing and efficient treatment to end users.

Stakeholders

  • Manufacturers & distributors of advanced wound dressings
  • Hospitals & clinics
  • Ambulatory surgery centers (ASCs)
  • Research & development companies
  • Clinical research organizations
  • Research laboratories and academic institutes
  • Brazil advanced wound dressing service providers
  • Government associations
  • Venture capitalists & investors

Report Objectives

  • To provide a clear definition and description of the Brazil advanced wound dressings market, categorizing it by product, wound type, and end user and forecasting its future growth
  • To offer comprehensive details about the primary factors influencing the market's growth trajectory, such as growth drivers, limitations, opportunities, and prevailing trends
  • To look at the market opportunities for those involved and provide details about how the main companies compete
  • To create profiles of the key companies and carefully analyze what products they offer, where they stand in the market, and what their main strengths are
  • To compare the companies in this market using a special framework that looks at different aspects of their business and how good their products are

 

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Brazil Advanced Wound Dressings Market

DMCA.com Protection Status